Senators Call For Report On State Of Psychedelic Research
Cannabis Law Report
MAY 29, 2022
8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. In 2017, FDA granted a request for Breakthrough Therapy designation for MDMA to treat PTSD. Clinical Trials and Human Subject Protections. DEA and the Controlled Substances Act.
Let's personalize your content